It was reported by the product specialist that a live clinical discussion session took place on (b)(6) 2020 via web conferencing.The session presented by (b)(6), md was titled "case experience and clinical data in over 250 cases using a hybrid biomaterial for hernia repair".In a later review of the presentation, the product specialist noted that after the presentation and during question and answering the physician stated that one or two infections had occurred and the device was excised.Gore was able to confirm with the physician that the product that was excised was gore® synecor intraperitoneal biomaterial.
|
Additional device codes and conclusion codes added.Procedure and specific patient factors may contribute to or cause infection, leading to contamination, exposure, lack of incorporation and/or seeding of device.Procedure related factors may include adherence to clinical guidelines on infection risk management, contamination of device prior to or during implant, and post-operative wound management.Patient risk factors may include diabetes, smoking, age, malnutrition, immunosuppressive therapy, post-operative instruction noncompliance, and hygiene.Individual medical decisions, if inconsistent and/or non-conforming to the device manufacturer¿s recommendations, ifu, or recognized best practices, may result in or contribute to an adverse event.There is insufficient information available for gore to reasonably draw conclusions related to aspects of the event, therefore conclusion code "4315 (-z): cause not established" is being used.Insufficient information may include limited or missing relevant medical records, involvement of multiple implanted devices (including non-gore devices) in the field of treatment, patient non-compliance, and/or a general lack of available detail or specificity related to an adverse event and/or device.
|